US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.5700
  • +0.0500+9.62%
Close Apr 1 16:00 ET
2.90MMarket Cap-0.12P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 17:23 ET

  • Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 14, 2024 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

    May 9, 2024 16:14 ET

    • Read more

    Market Insights

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    OKAY
    833230
    +29.96%
    CHANGFU CO.,LTD
    871396
    +24.59%
    Gansu Longshenrongfa Pharmaceutical Industry
    300534
    +20.05%
    4
    Tibet Duo Rui Pharmaceutical
    301075
    +20.02%
    5
    Chengda Pharmaceuticals
    301201
    +20.01%
    Log In for the Full List
    Unlock Now

    Investment Course

    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

    Discussing

    FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
    🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
    FOMC Press Conference, March 19, 2025

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.